These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20547582)

  • 1. Analgesics, sedatives and neuromuscular blockers as part of end-of-life decisions in Dutch NICUs.
    Laing IA; Piyasena C
    Arch Dis Child Fetal Neonatal Ed; 2010 Sep; 95(5):F385. PubMed ID: 20547582
    [No Abstract]   [Full Text] [Related]  

  • 2. Analgesics, sedatives and neuromuscular blockers as part of end-of-life decisions in Dutch NICUs.
    Verhagen AA; Dorscheidt JH; Engels B; Hubben JH; Sauer PJ
    Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F434-8. PubMed ID: 19574256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication regimes in the context of end-of-life decisions in neonatology: legal considerations with regard to Dutch NICU-practice.
    Dorscheidt JH; Verghagen E; Sauder PJ; Hubben JH
    Med Law; 2012 Dec; 31(4):671-85. PubMed ID: 23447910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical and legal acceptability of the use of neuromuscular blockers (NMBs) in connection with abstention decisions in Dutch NICUs: interviews with neonatologists.
    Moratti S
    J Med Ethics; 2011 Jan; 37(1):29-33. PubMed ID: 21030475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication regimes in the context of end-of-life decisions in neonatology: legal considerations with regard to Dutch NICU-practice.
    Dorscheidt JH; Verhagen E; Sauer PJ; Hubben JH
    Med Law; 2013 Jun; 32(2):215-29. PubMed ID: 23967795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Palliative care after neonatal intensive care: Contributions of Leonetti Law and remaining challenges].
    Kuhn P; Dillenseger L; Cojean N; Escande B; Zores C; Astruc D
    Arch Pediatr; 2017 Feb; 24(2):155-159. PubMed ID: 28041869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whom are we comforting? An analysis of comfort medications delivered to dying neonates.
    Janvier A; Meadow W; Leuthner SR; Andrews B; Lagatta J; Bos A; Lane L; Verhagen AA
    J Pediatr; 2011 Aug; 159(2):206-10. PubMed ID: 21353679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When hope fades.
    Ortolon K
    Tex Med; 2006 Oct; 102(10):33-6. PubMed ID: 17628961
    [No Abstract]   [Full Text] [Related]  

  • 9. End-of-life decisions in Dutch neonatal intensive care units.
    Verhagen AA; Dorscheidt JH; Engels B; Hubben JH; Sauer PJ
    Arch Pediatr Adolesc Med; 2009 Oct; 163(10):895-901. PubMed ID: 19805707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withholding treatment, withdrawing treatment, and palliative care in the neonatal intensive care unit.
    Walther FJ
    Early Hum Dev; 2005 Dec; 81(12):965-72. PubMed ID: 16274940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician medical decision-making at the end of life in newborns: insight into implementation at 2 Dutch centers.
    Verhagen AA; van der Hoeven MA; van Meerveld RC; Sauer PJ
    Pediatrics; 2007 Jul; 120(1):e20-8. PubMed ID: 17606544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Looking beyond the law to improve end-of-life care.
    Zuckerman C
    Generations; 1999; 23(1):30-5. PubMed ID: 17144036
    [No Abstract]   [Full Text] [Related]  

  • 13. [End of life care in intensive care units].
    Gardaz V; Doll S; Ricou B
    Rev Med Suisse; 2011 Dec; 7(321):2440-3. PubMed ID: 22279862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conflicts about end-of-life decisions in NICUs in the Netherlands.
    Verhagen AA; de Vos M; Dorscheidt JH; Engels B; Hubben JH; Sauer PJ
    Pediatrics; 2009 Jul; 124(1):e112-9. PubMed ID: 19564256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Palliative care in the neonatal period. Part one: general considerations].
    Bétrémieux P; Gold F; Parat S; Caeymaex L; Danan C; De Dreuzy P; Vernier D; Viallard ML; Kuhn P
    Arch Pediatr; 2010 Apr; 17(4):409-12. PubMed ID: 20206482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs used for comfort care after withdrawal of intensive treatment in tertiary neonatal units in the UK.
    Chaudhary R; Silwal A; Gupta A; Kelsall W
    Arch Dis Child Fetal Neonatal Ed; 2012 Nov; 97(6):F487. PubMed ID: 22581792
    [No Abstract]   [Full Text] [Related]  

  • 17. [Very premature births: Dilemmas and management. Second part: Ethical aspects and recommendations].
    Moriette G; Rameix S; Azria E; Fournié A; Andrini P; Caeymaex L; Dageville C; Gold F; Kuhn P; Storme L; Siméoni U;
    Arch Pediatr; 2010 May; 17(5):527-39. PubMed ID: 20223643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infants' best interests in end-of-life care for newborns.
    Willems DL; Verhagen AA; van Wijlick E;
    Pediatrics; 2014 Oct; 134(4):e1163-8. PubMed ID: 25246628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. End of life, death and dying in neonatal intensive care units in Latin America.
    Fajardo CA; González S; Zambosco G; Cancela MJ; Forero LV; Venegas M; Baquero H; Lemus-Varela L; Kattan J; Wormald F; Sola A; Lantos J
    Acta Paediatr; 2012 Jun; 101(6):609-13. PubMed ID: 22536812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethical aspects of withdrawing/withholding renal replacement therapies on patients in acute renal failure in an intensive care unit.
    Draper H
    EDTNA ERCA J; 2002; Suppl 2():39-42. PubMed ID: 12371721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.